Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview

23847studies shown

Showing 23,425-23,436 of 23,847

Drug study icon

TerminatedNCT04602494

Varenicline For Nicotine Vaping Cessation In Non Smoker Vaper Adolescents

This summary needs review. Please check the official study record and contact the research team for details.

In Boston

AddictionDrugFrom 18 Years to 25 Years

Countries: United States
Sponsor: Massachusetts General Hospital
Condition: Addiction

Drug study icon

CompletedNCT00860028

Varenicline for Smoking Cessation in Heavy Drinking Smokers

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed

AddictionDrugFrom 18 Years to 75 Years

Countries
Sponsor: Yale University
Condition: Addiction

Drug study icon

WithdrawnNCT05294263

Varenicline for Cannabis and Tobacco Use Disorders in Veterans

This summary needs review. Please check the official study record and contact the research team for details.

In Charleston

AddictionDrugOver 18 Years

Countries: United States
Sponsor: VA Office of Research and Development
Condition: Addiction

Drug study icon

CompletedNCT00813800

Varenicline in Bipolar Depressed Patients

This summary needs review. Please check the official study record and contact the research team for details.

In Rochester

Bipolarity, DepressionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Mark Frye
Condition: Bipolarity, Depression

Drug study icon

CompletedNCT00790569

Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking

This summary needs review. Please check the official study record and contact the research team for details.

In Providence

AddictionDrugFrom 18 Years to 120 Years

Countries: United States
Sponsor: Butler Hospital
Condition: Addiction

Drug study icon

CompletedNCT01771627

Varenicline or Nicotine Patch in Promoting Smoking Cessation Among Current Smokers

This summary needs review. Please check the official study record and contact the research team for details.

In Buffalo

AddictionDrugOver 18 Years

Countries: United States
Sponsor: Roswell Park Cancer Institute
Condition: Addiction

Drug study icon

CompletedNCT01378858

Varenicline Smoking Cessation Treatment for Methadone Maintenance Patients

This summary needs review. Please check the official study record and contact the research team for details.

In The Bronx

AddictionDrugOver 18 Years

Countries: United States
Sponsor: Albert Einstein College of Medicine
Condition: Addiction

Drug study icon

CompletedNCT02892110

Varenicline Treatment for Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In Charleston

AddictionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Medical University of South Carolina
Condition: Addiction

Drug study icon

CompletedNCT01010204

Varenicline Treatment for Smoking Cessation in people with Bipolarity

This study exists to understand how smoking support or smoking-related treatment holds up over time after the earliest research stage. Researchers are trying to understand whether smoking support or smoking-related treatment can better prevent setbacks and support longer-term stability.

Multiple locations, including DuBois

BipolarityDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: K.N. Roy Chengappa
Condition: Bipolarity

Drug study icon

CompletedNCT00727103

Varenicline Treatment in Alcohol and Nicotine Dependent people with Schizophrenia

This study exists to see whether smoking support or smoking-related treatment is workable and worth testing more broadly. Researchers are trying to understand whether smoking support or smoking-related treatment can improve attention, thinking, or day-to-day functioning.

In Syracuse

Schizophrenia, AddictionDrugFrom 18 Years to 69 Years

Countries: United States
Sponsor: State University of New York - Upstate Medical University
Condition: Schizophrenia, Addiction

Other study type icon

CompletedEUCTR 2019-003720-20

Varenicline Versus Cytisine for Smoking Cessation in the Primary Care Setting in Croatia and Slovenia - a Controlled study

This study is completed in Slovenia. It focuses on Addiction.

In Slovenia

AddictionOther

Countries: Slovenia
Sponsor: University of Zagreb School of Medicine
Condition: Addiction

Drug study icon

CompletedNCT01011829

Varenicline vs Placebo for Methamphetamine Dependence

This summary needs review. Please check the official study record and contact the research team for details.

In Los Angeles

AddictionDrugOver 18 Years

Countries: United States
Sponsor: University of California, Los Angeles
Condition: Addiction

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.